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The mammalian homeobox gene pdx-1 is expressed in pluripotent precursor cells in the dorsal and ventral
pancreatic bud and duodenal endoderm, which will produce the pancreas and the rostral duodenum. In the
adult, pdx-1 is expressed principally within insulin-secreting pancreatic islet b cells and cells of the duodenal
epithelium. Our objective in this study was to localize sequences within the mouse pdx-1 gene mediating
selective expression within the islet. Studies of transgenic mice in which a genomic fragment of the mouse pdx-1
gene from kb 24.5 to 18.2 was used to drive a b-galactosidase reporter showed that the control sequences
sufficient for appropriate developmental and adult specific expression were contained within this region. Three
nuclease-hypersensitive sites, located between bp 22560 and 21880 (site 1), bp 21330 and 2800 (site 2), and
bp 2260 and 1180 (site 3), were identified within the 5*-flanking region of the endogenous pdx-1 gene.
Pancreatic b-cell-specific expression was shown to be controlled by sequences within site 1 from an analysis of
the expression pattern of various pdx-1–herpes simplex virus thymidine kinase promoter expression constructs
in transfected b-cell and non-b-cell lines. Furthermore, we also established that this region was important in
vivo by demonstrating that expression from a site 1-driven b-galactosidase reporter construct was directed to
islet b-cells in transgenic mice. The activity of the site 1-driven constructs was reduced substantially in b-cell
lines by mutating a hepatocyte nuclear factor 3 (HNF3)-like site located between nucleotides 22007 and
21996. Gel shift analysis indicated that HNF3b present in islet b cells binds to this element. Immunohistochemical studies revealed that HNF3b was present within the nuclei of almost all islet b cells and subsets of
pancreatic acinar cells. Together, these results suggest that HNF3b, a key regulator of endodermal cell lineage
development, plays an essential role in the cell-type-specific transcription of the pdx-1 gene in the pancreas.
Endocrine cells of the adult pancreas are organized into the
islets of Langerhans, which are distributed throughout the exocrine tissue. The four endocrine islet cell types, a, b, d, and PP,
express glucagon (a), insulin (b), somatostatin (d), or pancreatic polypeptide (PP) as their principal differentiated hormone
products (reference 2 and references therein). Mammalian
PDX-1 was first characterized as a transcription factor of the
somatostatin (29, 31) and insulin (36, 39) genes by its ability to
bind to and stimulate AT-rich cis elements within their transcription control regions. This gene product was referred to in
these studies as the IPF-1 (36), STF-1 (29), or IDX-1 (31)
protein, but the gene will be referred to here as pdx-1 (for
pancreatic and duodenal homeobox gene 1), the name given by
the International Committee on Standardized Genetic Nomenclature for Mice. In the adult pancreas, PDX-1 is found
within the nuclei of essentially all insulin-producing islet b cells
(91%) and a subset of somatostatin (15%) producing d cells
but is almost undetectable in other pancreatic cell types (18,
38–40).
Together, these data implicated PDX-1 as a vital regulator
in a genetic program leading to the proper development of the
pancreas and duodenum. However, the factors that control
PDX-1 expression and activity during embryogenesis or in
adult islet and duodenal cells are not understood. One approach to determining the molecular mechanisms influencing
PDX-1 transcription is to identify those factors that commit
specific cells to express this gene product. Since PDX-1 is
expressed both in multipotential endodermally derived precursor cells in embryos and in fully differentiated cell types in
adults, we postulated that transcription factors important for

During mammalian pancreatic development, common multipotential endodermally derived precursors in the early embryo undergo a series of specific changes that lead to the
differentiated exocrine and endocrine pancreas. The dorsal
and ventral pancreatic primordia first appear as evaginations
of the gut endoderm on day 9 postcoitum (p.c.) in the mouse.
The first cells to express differentiated pancreatic hormone
markers in these buds are found in embryos of about 20
somites, corresponding to 9.5 days p.c. (15, 18, 41, 55). The two
buds grow independently, forming both exocrine and endocrine tissues, and finally merge on day 10.5 p.c. (41). Recent
studies indicate that expression of the PDX-1 homeoprotein in
a common precursor cell population is essential for the development of the endocrine and exocrine compartments of the
pancreas, with pancreatic development becoming arrested at a
very early post-bud stage in homozygous pdx-1 mutant mice (1,
25, 35). PDX-1 was also recently shown to be essential for
pancreatic development in humans (52). However, pdx-1 not
only is important in pancreatic development but is also expressed in the duodenum (18), and the morphology and differentiation of the rostral duodenum are affected in pdx-12/2
mice (35). The regulatory mechanisms that orchestrate the
complex developmental transitions involved in cellular differentiation during embryogenesis have not been defined, but
these studies clearly demonstrate that PDX-1 is essential for
this process.
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differentiation and lineage commitment pathways would be
important in PDX-1 expression.
In this paper, we identify sequences within the mouse pdx-1
gene that regulate pancreatic b-cell-type-specific transcription.
Our analyses reveal that selective expression is controlled by
the region from bp 22560 to 21880, which was also found to
direct appropriate developmental and adult specific expression
in transgenic animals. In addition, we demonstrate that a hepatocyte nuclear factor 3 (HNF3)-like element at bp 22007 to
21996 is important for the b-cell-type-specific activity of the
22560/21880 bp region. We provide evidence that the positive-acting factor interacting with this element is HNF3b, a
protein in the fork head/winged helix transcription factor family that is essential for endodermal cell lineage development
(for a review, see reference 62). We propose that HNF3b acts
in concert with an islet b-cell-enriched factor(s) to direct the
selective expression of the pdx-1 gene.
MATERIALS AND METHODS
pdx-1 transgenic constructs and generation of transgenic mice. The pdx-1–bgalactosidase (b-gal) (lacZ) transgene construct XSlacZ contains 9.3 kb of
genomic sequence, lying between an upstream XbaI site and a SmaI site within
the homeobox in exon 2, fused in-frame to a b-gal cassette from pPD1.27lacZ,
which encodes bacterial b-gal with simian virus 40 nuclear localization and
polyadenylation signals (14). XSlacZPS was generated by adding the 39 3.5-kb
PstI-SalI fragment, containing sequences extending from just 59 of the stop codon
to the 39 end of an approximately 15-kb lambda genomic clone (35). The PBhsplacZ transgene contains 1 kb of 59 genomic sequence from the PstI site at kb
22.7 to the BstEII site at kb 21.7 upstream of lacZ. All the constructs were
confirmed by restriction mapping and by partial-sequence analysis of the junctions. DNA was CsCl purified, and the entire insert was released from the vector
by SalI digestion, isolated by low-melting-temperature agarose gel electrophoresis, and purified by standard methods. A 1- to 5-pl volume of a 3-ng/ml DNA
solution was injected into the pronucleus of one-cell embryos from B6D2 females, which were then implanted into pseudopregnant ICR females. Some F0
founder embryos were dissected 11.5 days p.c. (XSlacZPS) to analyze the pdx-1driven b-gal expression pattern. Transgenic lines were subsequently generated
for all three constructs.
Detection of b-gal. Embryos at 11.5 days p.c. (XSlacZPS) or digestive organs
from 2-day-old pups (PB-hsplacZ) and adult pancreata were dissected in phosphate-buffered saline (PBS) and kept on ice for 10 min until fixation. The tissues
were fixed in 4% paraformaldehyde at 4°C for 30 to 40 minutes, permeabilized
for 15 to 30 minutes in 2 mM MgCl2–0.01% sodium deoxycholate–0.02% Nonidet P-40, in PBS, and reacted with 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-Gal) substrate solution overnight at room temperature (6). Digestive
organs from 2-day-old pups were incubated at 4°C to minimize background
expression within the intestine. The tissues were then postfixed in 4% paraformaldehyde at 4°C and rinsed with PBS. Genotyping determined that X-Gal
reactivity was detected only in transgenic embryos, demonstrating the specificity
of the reaction for the transgene. Adult pancreatic tissue was processed, and
15-mm cryostat sections were cut (6). Alternatively, pancreatic tissue was fixed in
4% paraformaldehyde in PBS for 1 h at 4°C; dehydrated for 1 h in a 70 to 100%
ethanol series, twice for 1 h in isopropanol, and for 1 h in isopropanol-paraplast
(50:50, vol/vol) at 56°C; and embedded in paraplast first for 1 h and then
overnight at 56°C. Serial 5-mm sections were taken and mounted on glass slides
with Sta-on (Surgipath Medical Industries, Inc.).
Genotyping. Embryos and adults were genotyped by Southern blot analysis
involving PvuII digestion, with a 726-bp PvuI internal lacZ fragment as a probe.
DNA from extraembryonic membranes, neonatal brain tissue or adult tails was
prepared and analyzed as described by Hogan et al. (20).
Cell culture and transfections. Monolayer cultures of HIT T-15 2.2.2 and
bTC3 cells were maintained as described previously (39, 57). Baby hamster
kidney (BHK) and NIH 3T3 cells were grown in Dulbecco modified Eagle
medium containing 10% (vol/vol) calf serum and 50 mg each of streptomycin and
penicillin per ml. The pdx-1–pTk constructs were transfected by either the calcium phosphate coprecipitation procedure (HIT T-15 and BHK) (56) or the
electroporation procedure (bTC3) (42). The precipitates (11 mg total) used for
the HIT T-15 and BHK transfections contained 1 mg of pdx-1–pTk and pRSV
LUC, while 10 mg of each of these plasmids (60 mg total) was used with bTC3
cells. The Rous sarcoma virus (RSV) enhancer-driven luciferase (LUC) expression plasmid, pRSV LUC (10), was used as a recovery marker. At 4 h after
addition of the calcium phosphate DNA precipitate, the cells were treated with
20% glycerol for 2 min and harvested 40 to 48 h after transfection. The chloramphenicol acetyltransferase (CAT) activity from the reporter plasmid was normalized to the LUC activity of the cotransfected internal control plasmid. LUC
and CAT enzymatic assays were performed as described by De Wet et al. (10)
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and Nordeen et al. (34), respectively. Each experiment was carried out three to
five times with at least two different plasmid preparations.
Transfection constructs. pdx-1 sequences were isolated from a complete
lambda clone insert (plasmid 572) containing a genomic fragment from approximately kb 26.8 to 18.2. All of the mouse pdx-1 gene promoter sequences were
cloned directly upstream of the herpes simplex virus thymidine kinase (HSV TK)
promoter region in the CAT expression vector, pTK(An) (23). The 59 and 39
pdx-1–pTk expression constructs were formed using existing restriction enzyme
sites. The 59 restriction enzyme, followed by the 39 restriction enzyme, was the
convention used in naming these pTk constructs. The internal deletion mutant,
PstBstpTk D22031/21996, was generated by removing sequences from 22031
(SphI) to 21996 (BstNI) from PstBstpTk. The site-directed mutants of PstBstpTk were generated by PCR by the method of Saiki et al. (44). The following
59 oligonucleotides were used for mutagenesis: PDX-1 binding site mutant
(PDX-1m), 59 CCAATTTACCAAAATGCATGCCAGTCGACCAGAAG 39;
M1, 59 CCAAAATGCATGCAATTAGCAACTCCTTGCTAAGCAAACATC
CGGG 39; M2, 59 CCAAAATGCATGCAATTAGACCAGAAGGTAGCCTA
AAACATCCTGGGGTGTGG 39; M3, 59 CCAAAATGCATGCAATTAG
ACCAGAAGTGCAAGCCCCACGAATGGGG TG TGGGT TAGGC 39; M4,
59 CCAAAATGCATGCAATTAGACCAGAAGGTAGAAGCAAACATCCT
GGG 39; M5, 59 CCAAAATGCATGCATGCAATTAGACCAGAAGTGCT
AATACCACATCCTGGGGTGTGG 3; M6, 59 CCAAAATGCATGCAAT
TAGACCAGAAGTGC TAAGCAAACAGAATGGGG TG TGGGTTAGGC
39. The mutated nucleotides are underlined. A 39 oligonucleotide containing
CAT gene sequences (59 AGCTCCTGAAAATCTCGCCAAGCT 39) was also
used in these PCRs. Each of the constructs was verified by DNA sequencing.
Electrophoretic mobility shift assays. Nuclear extracts were prepared from
bTC-3, HIT T-15, NIH 3T3, and BHK cells by the method of Sadowski and
Gilman (43), except that the cells were lysed by Dounce homogenization (20
strokes with pestle A). Human islet extracts were prepared by the methods
described by Schreiber et al. (47). Binding reactions (20-ml reaction mixtures)
were conducted in the binding buffer [20 mM HEPES (pH 7.9), 20 mM KCl, 50
mM NaCl, 1 mM dithiothreitol, 1 mg of poly(dl-dC), 10% (vol/vol) glycerol] of
Wang et al. (53). Approximately 4 mg of extract protein was used per gel mobility
shift sample. Double-stranded oligonucleotides to detect the pdx-1 22017/21991
element and the USF factor binding were end labeled with [a-32P]dATP and the
Klenow fragment of Escherichia coli DNA polymerase I and used as probes. The
conditions for the competition analyses were the same, except that the specific
competitor DNAs were included in the mixture (in the amounts detailed in the
figure legends) prior to addition of extract. The double-stranded oligonucleotides were as follows: wild type, 22017 ATTAGTGCTAAGCAAACA
TCCTGGGG 21991; M4, 59 ATTAGGTAGAAGCAAACATCCTGGGG 39;
M5, 59 ATTAGTGCTAATACCACATCCTGGGG 39; M6, 59 ATTAGTGC
TAAGCAAACAGAATGGGG 39; and USF, 59 TAGGTGTAGGCCACGTGA
CCGGGTGTTC 39 (16). The mutated nucleotides are underlined. The rabbit
anti-mouse HNF3b (3 ml) or control preimmune polyclonal serum (3 ml) was
preincubated with extract protein for 10 min at room temperature prior to
initiation of the DNA-binding reactions. The HNF3b antibody was raised against
amino acids 1 to 117 of the mouse HNF3b protein (30); this antiserum appears
to be HNF3b specific (30). The samples were subjected to electrophoretic separation on a 6% nondenaturing polyacrylamide gel at 150 V for 2 h under
high-ionic-strength polyacrylamide gel electrophoresis conditions (39). The gel
was then dried, and labeled DNA-protein complexes were localized by autoradiography.
Isolation of nuclei and nuclease-HS-site analysis. Nuclei were isolated from
bTC-3 and NIH 3T3 cells as described previously (21), except that the cells were
broken by Dounce homogenization (20 strokes with pestle A). The nuclear pellet
was resuspended in nuclease digestion buffer (10 mM Tris [pH 7.4], 50 mM NaCl,
0.5 mM spermidine, 0.15 mM spermine, 0.25 M sucrose) at 25 absorbance units
at 260 nm (A260 U)/ml. Nuclease digestions (5 A260 U of nuclei in 0.5 ml) were
started by the addition of micrococcal nuclease (MNase; Pharmacia) or DNase
I (DPFF grade; Worthington), MgCl2 (10 mM), and CaCl2 (1 mM). After
incubation for 5 min at 25°C, the reaction was stopped by adding sodium dodecyl
sulfate (1%) and EDTA (25 mM), and genomic DNA was isolated by the method
of Herrmann and Frischauf (19). The purified DNA (20 mg/lane) was digested to
completion with EcoRI and PstI for analysis of 59 and 39 hypersensitive (HS)
sites, respectively. The fragmented DNA was resolved by electrophoresis on a
1% agarose gel and transferred to a Zeta probe membrane (Bio-Rad) as described by the supplier. The membrane was probed with the mouse pdx-1 PstIEcoRI fragment (109 cpm/mg) at nucleotides 11154 (PstI) to 11954 (EcoRI).
High-stringency conditions used for probing and washing the membrane were as
described by the supplier. The labeled DNA bands were localized by autoradiography.
Immunohistochemistry. Adult mouse liver and pancreatic tissues were embedded and sectioned as described above. The sections were deparaffinized and
rehydrated with distilled water. Immunoperoxidase staining was carried out
essentially as described by Jetton et al. (24), except that endogenous peroxidase
activity was quenched with 0.6% H2O2 in methanol for 30 min. Primary antibodies were used at the following dilutions: guinea pig anti-insulin (Linco), 1:500,
and rabbit anti-mouse HNF3b (a gift from Brigid Hogan), 1:10 and 1:50. The
primary antibodies were incubated overnight at 4°C. Secondary antibodies, either
donkey anti-guinea pig–horseradish peroxidase or goat anti-rabbit–horseradish
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FIG. 1. Expression of a pdx-1–lacZ fusion gene in transgenic mice. (A) Diagrammatic representation of the pdx-1 locus. Thin lines indicate noncoding sequences,
and boxes represent the first and second exons. The homeodomain in exon 2 is depicted by the hatched box. The lower line represents the genomic sequences used
to generate the lacZ-containing transgene, XSlacZPS. (B) Lateral view of a whole day 11.5 p.c. transgenic embryo stained with X-Gal to visualize the pdx-1–lacZ
expression domain (blue). Expression is present within a restricted region of the developing posterior foregut. The melanized eye is visible to the upper left. The anterior
is toward the top. Bar, 330 mm. (C) Higher-magnification view of panel B, showing b-gal staining in the dorsal and ventral pancreatic buds and the rostral duodenum.
Bar, 100 mm. (D) In sectioned adult pancreatic tissue, pdx-1–b-gal expression is seen in the majority of islet b-cells and at lower intensity within acinar cells of some
pancreatic lobes, but not others. Bar, 50 mm. Abbreviations: Xb, XbaI; d, dorsal pancreatic bud; v, ventral bud; du, duodenum; g, gallbladder and cystic duct; a, acinar
cells; i, islet.

peroxidase (Jackson Immunoresearch; 1:500), were incubated for 1 h at room
temperature. Immunoperoxidase was detected with diaminobenzidine-H2O2 for
2 to 5 min. The samples were viewed under bright-field illumination and photographed with Kodak Ektachrome 64T film.

RESULTS
pdx-1 promoter activity in transgenic mice. A transgenic
approach was used to determine whether a 15-kb lambda
genomic clone contained cis-acting sequences sufficient to recapitulate normal pdx-1 expression. A construct replacing most
of the second exon, including the homeobox, with a lacZ cassette was used to generate a reporter transgene plasmid,
XSlacZPS (Fig. 1A), in which b-gal activity was controlled by
pdx-1 sequences. Three of nine F0 embryos sacrificed at 11.5
days p.c. for b-gal staining were transgenic and showed equivalent staining patterns (Fig. 1B). The b-gal staining was detected in a restricted region of the developing foregut corresponding to the dorsal and ventral pancreatic buds and the
endoderm of the developing rostral duodenum (Fig. 1C).
Transgenic mouse pups were also used to establish lines corresponding to the same pdx-1–lacZ construct. The adult pan-

creatic expression of the b-gal reporter in these lines occurred
principally in the islets, although staining was also detected
within acinar cells in some, but not all, pancreatic lobes (Fig.
1D). Multiple lines gave the same expression pattern (data not
shown). The activity of the pdx-1–lacZ transgene reproduces to
a large degree the expression pattern observed after recombination of lacZ into the endogenous locus (35). We conclude
from these results that the regulatory elements necessary for
appropriate development- and differentiation-specific transcription are present in the kb 24.5 to 18.2 region of the pdx-1
gene, especially in relation to the adult cell pattern.
Identification of nuclease-HS sites within the 5* region of
the pdx-1 gene in b cells. Genes that are transcriptionally active
or potentially active are contained in a chromatin conformation different from that of inactive genes (5, 51, 58). The
binding of nonhistone proteins, such as transcription factors,
contributes to the altered nucleosomal organization in active
genes (11, 17). The binding of these factors renders these
regions susceptible to digestion by DNase I and micrococcal
nuclease (MNase). We probed for DNaseI and MNase HS
sites within the pdx-1 gene in a PDX-1-expressing mouse islet
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FIG. 2. Identification of 59 flanking nuclease-HS regions in the mouse pdx-1 gene. (A) Genomic organization of the pdx-1 gene. The location of the exons (black
boxes) and flanking regions of pdx-1 are shown. The locations of the EcoRI and PstI restriction sites are shown. The PstI-EcoRI fragment at bp 11154 to 11954 was
used as the probe (gray box). Nucleotide numbering is relative to the S1 transcription start site in the rat pdx-1 gene (48); the sequences of the rat and mouse pdx-1
genes within this region are highly conserved (data not shown). The 59 and 39 HS sites were determined by EcoRI and PstI digestion, respectively. The HS sites in bTC3
cells were located at bp 22560 to 21880 (site 1), 21330 to 2800 (site 2), and 2260 to 1180 (site 3). (B to F) bTC-3 (B, C, E, and F) and NIH 3T3 (D) nuclear DNA
was either not digested (2) or digested with 2, 4, and 8 U of DNase I per ml (B and F) or 20, 50, and 100 U of MNase per ml (C to E). EcoRI (B to D) and PstI (E
and F) restriction enzyme digests are shown. Analysis of 59 and 39 HS sites is shown in panels B to D and panels E and F, respectively. The exposure time in panels
B, E, and F was 24 h; that in panels C and D was 48 h. The degrees of MNase and DNase I digestion were comparable in all cell types as determined by ethidium bromide
staining of the agarose gels. The 59 HS sites in bTC-3 cells are labeled as described in the text. Abbreviations: Xb, XbaI; PB, parent band.

b-cell line, bTC-3, and a nonexpressing mouse fibroblast cell
line, NIH 3T3. Most of the region of the pdx-1 gene that
controlled appropriate developmental and islet b-cell-specificexpression in transgenic mice was analyzed in these experiments (Fig. 2).
Nuclease-HS sites were detected in bTC-3 cells at bp 22560
to 21880 (termed site 1), 21330 to 2800 (site 2), and 2260 to
1180 (site 3); DNase I (Fig. 2B) and MNase (Fig. 2C) resulted
in the same nuclease digestion pattern. The entire 39 region
included in this analysis (approximately bp 1175 to 15000)
was resistant to nuclease attack in bTC-3 cells (Fig. 2E and F).
HS sites were also not detected within either the 59 (Fig. 2D)
or 39 (data not shown) region of the pdx-1 gene in NIH 3T3
cells.
These results localized potential sequences controlling transcription of the pdx-1 gene in bTC-3 cells to the 59 flanking
region. Since the HS sites lie within the region of the pdx-1
gene that defined selective expression in transgenic mice, we
infer that the 22560 to 21880, 21330 to 2800, and/or 2260 to
1180 sequences are used by endogenous factors essential in
directing islet b-cell-specific expression.
Sequences between bp 22560 and 21880 control b-celltype-specific expression. As a first step toward identifying cis
elements within pdx-1 that can direct selective expression in b
cells, pdx-1 sequences were subcloned directly upstream of the

HSV TK minimal promoter sequences in the CAT expression
plasmid, pTk(An). Their activity was compared after transfection in two pancreatic b-cell lines, HIT T-15 and bTC-3, and
the nonpancreatic BHK cell line. pdx-1 is expressed only in the
b-cell lines (39). We reasoned that pdx-1–pTK constructs containing sequences that mediate b-cell-specific expression
would be more active in the b-cell lines. CAT activity from
each transfected construct was normalized to the activity obtained from a cotransfected RSV LUC expression plasmid.
The pdx-1 sequences analyzed with the pTk(An) vector
spanned the region shown to be sufficient for selective expression in transgenic mice (Fig. 3). The extent of b-cell-specific
activation was expressed as the ratio of pdx-1–pTk activity in
either HIT T-15 or bTC-3 cells to that in BHK cells. The only
constructs that were more active in b cells were those containing 59 flanking sequences, such as XbSacpTK and XbBstpTK.
None of the 39-flanking-sequence-driven constructs were expressed selectively (Fig. 3, compare PstHindpTk, XbXbpTk, or
XbXb39pTk with XbSacpTk). These findings supported our
proposal that the sequences controlling pdx-1 expression were
spanned by the 59 flanking nuclease-HS sites. However, we also
found that pdx-1–pTk constructs containing only HS site 2
(XmnSacpTk), HS site 3 (BglPst[A]pTk), or both HS sites 2
and 3 (BstSacpTk) were equally active in pdx-1-expressing and
nonexpressing cells (Fig. 3). A recent study of the rat pdx-1
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FIG. 3. Sequences in the 59 flanking region impart b-cell-specific expression. A schematic of the mouse pdx-1 gene with the nuclease-HS sites at nucleotides 22560
to 21880 (site 1), 21330 to 2800 (site 2), and 2260 to 1180 (site 3) is shown. The thick line spans the pdx-1 sequences present in the pdx-1–pTk chimera. Each
construct was named for the 59-end followed by the 39-end restriction enzyme site in the pdx-1 gene, except BglPst[A]pTk, whose pdx-1 sequences were in the antisense
orientation. The pdx-1–pTk constructs were transfected into HIT T-15, bTC-3, and BHK cells. The CAT activity in each sample was normalized to the LUC activity
from the cotransfected pRSV LUC plasmid. Results are represented relative to pTK(An)CAT activity 6 standard deviation. The normalized pTK(An)CAT activity
in HIT T-15, bTC-3, and BHK cells was 30,382 6 3,342, 5,457 6 1,350, and 22,996 6 3,500 cpm, respectively. The ratio of pdx-1–pTk activity in b cells (i.e., HIT T-15
or bTC-3) to that in BHK cells represents the fold b-cell-specific activation. The activity of the 39 flanking region constructs was the same when pdx-1 gene sequences
were cloned in their antisense orientation (data not shown). Abbreviations: Bgl, BglII; Bst, BstEII; Hind, HindIII; Pst, PstI; Sac, SacI; Xb, XbaI; Xmn, XmnI.

gene also indicates that HS site 3 does not contain positiveacting elements driving selective expression (48). Furthermore,
we have found that the sequences of the mouse pdx-1 gene
within site 3 are closely related to those in the rat (data not
shown) and that the number and locations of the transcription
start sites are similar (59).
In contrast to the HS site 2- and 3-driven constructs, the HS
site 1-driven construct, XbBstpTk, mediates more efficient
transcription from the TK promoter in HIT T-15 and bTC3
cells (Fig. 3). However, XbBstpTk and XbSacpTk were also
less active than the HS site 2- or 3-driven construct in BHK
cells (Fig. 3), indicating that HS 1 sequences may function as a
site of repression in nonexpressing cells. We conclude that
sequences spanned by nuclease-HS site 1 at bp 22560 to
21880 are sufficient to support pancreatic b-cell-specific transcription.
To identify more precisely the sequences involved in controlling b-cell-type expression, we generated a series of 59 and
39 flanking deletion mutants spanning the region containing
HS site 1 (Fig. 4). Compared to XbBstpTk, selective expression
in HIT T-15 versus that in BHK cells was lost by deletion of HS
site 1 (Fig. 4, compare XbPvupTk, XbSphpTk, or XbKpnpTk
with XbBstpTk). In contrast, a construct that completely
spanned this site (PstBstpTk) was the most effectively expressed pdx-1–pTk chimera. There was a two- to threefold
drop in the b-specific activation when sequences from the 59
flanking region were deleted from PstBstpTk (Fig. 4, compare
KpnBstpTk, StuBstpTk, or XmnBstpTk with PstBstpTk), indicating that essential cis elements were being removed in the
process. The same preferential activation pattern was also observed with PstBstpTk in bTC3 (data not shown). These studies strongly indicated that HS site 1 sequences alone could
direct b-cell-specific activation.
The bp 22560 to 21880 region directs islet b-cell expression in transgenic animals. To determine the relevance of the
b-cell-specific regulatory sequences identified in b-cell lines to
pdx-1 regulation in vivo, lacZ transgenes spanning HS site 1
were generated. The first contained a 2.8-kb XbaI-XhoI fragment from the 59 end of the XSlacZPS transgene, and the
second (PB-hsplacZ) corresponded to the PstI-BstEII region
shown in Fig. 4. The PstI-BstEii region is found within the

XbaI-XhoI fragment. Transgenic embryos carrying the XbaIXhoI-hsplacZ transgene were analyzed at 14.5 days p.c. Expression of b-gal from the lacZ transgene was detected only in
pancreatic islets and not in any other cell population, including
other cell types in which pdx-1 is normally expressed (data not
shown). A line of mice carrying the PB-hsplacZ transgene was
also generated, and analysis of tissues from 2-day-old pups
from this line revealed b-gal expression in all islets (Fig. 5A) as
well as the pyloric sphincter and the common bile duct. Within
the pancreas itself, insulin colocalized with b-gal expression,
demonstrating that these were indeed b cells (Fig. 5B). PstBstdriven expression of b-gal was also localized to b cells in a
10-month-old adult founder male (data not shown), suggesting
that this region can drive reporter expression to islet b cells in
early embryos, neonates, and adults. We conclude that the
evidence for tissue- and cell-type-specific regulation of pdx-1
conferred by PstBst in cell lines is borne out in vivo and that
the PstBst region interacts with factors essential for controlling
b-cell-specific transcription of the pdx-1 gene.
Identification of an HNF3-like element involved in regulating b-cell-specific expression. In cell culture, selective expression from PstBstpTk was eliminated either by 59-end deletions
to the Sph1 site or by 39-end deletions to the same site (Fig. 4,
compare PstSphpTk and SphBstpTk with PstBstpTk). Thus,
both the 59 and 39 regions contain key cis elements required for
preferential expression in b cells. Given its relatively small size,
we have initially focused on characterizing the importance of
the SphBst region, which spanned nucleotides 22030 to
21924, in mediating transcriptional activation in b cells.
When the region from bp 22031 to 21996 was deleted from
PstBstpTk, a threefold decrease in HIT T-15 cell activity was
reproducibly observed (Fig. 6B). Block mutations were made
throughout this region to identify the control element(s) removed as a result of the internal deletion mutation (Fig. 6B).
Mutations toward the 39 end of the bp 22031 to 21996 region
reduced PstBstpTk activity (Fig. 6, compare M2 and M3 with
PstBstpTk), while mutations at the 59 end had little or no effect
(Fig. 6, compare PDX-1m and M1 with PstBstpTk). Mutations
within an AT-rich element at bp 22031 to 22015 had no effect
on PstBstpTk activity (Fig. 6B), although these sequences
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FIG. 4. Selective expression properties of the nuclease-HS site 1 sequences. A map of the mouse pdx-1 gene sequences in the pTk(An) CAT expression vectors is
shown. The thick line spans the region present in the construct. Each chimera was named by the 59-end followed by the 39-end restriction site used in pdx-1–pTk
construction. A diagram of the 59 flanking region of the pdx-1 gene with the bp 22560 to 21880 (site 1), 21330 to 2800 (site 2), and 2260 to 1180 (site 3) nuclease-HS
sites is shown. The activities were calculated as described in the legend to Fig. 4. The ratio of the pdx-1–pTk to pTk activity in HIT T-15 divided by that in BHK cells
is presented as the mean 6 standard deviation of results from at least three independent transfections. Abbreviations: Bst, BstEII; Xb, XbaI.

could bind effectively to PDX-1 in vitro (Fig. 6B, compare
PstBstpTk to PDX-1m).
The region defined as mutationally sensitive by the PstBstpTk M2 and M3 mutants in Fig. 6B had substantial similarity
to a consensus HNF3-binding site, with 11 of the 12 nucleotides at bp 22006 to 21994 matching a consensus HNF3 site
(Fig. 6A). Analysis of small block mutations spanning these
sequences strongly indicated that the HNF3-like site was required for maximal activity in HIT T-15 cells. Thus, two mutations that reside outside or within a less conserved portion of
this element had little effect on activity (Fig. 6B, compare
PstBstpTk M4 and PstBstpTk M6 with PstBstpTk), whereas a
core region mutation reduced PstBstpTk activity to the level of
that in the bp 22031 to 21996 internal deletion mutant (Fig.
6B, compare PstBstpTk M5 with PstBstpTk D22031/21996).
This HNF3 site mutant also reduced PstBstpTk activity in
bTC-3 cells (Fig. 6C). In contrast, neither wild-type nor HNF3
site mutant PstBst region sequences influenced pTk activity in
either non-pdx-1-expressing liver H4IIE (Fig. 6C) or BHK
(data not shown) cells. These results strongly indicate that the
HNF3-like site at bp 22006 to 21994 binds a factor required
for HS site 1-driven expression in b cells.
HNF3b binds to the bp 22006 to 21994 element in b cells.
The HNF3 family of transcription factors contain a conserved
110-amino-acid DNA-binding domain (62). Mammalian proteins in this family include factors enriched in both liver and
pancreatic cells, like HNF3a, HNF3b, and HNF3g (32). The
gel mobility shift assay was used to test the cell type specificity
of the factors interacting with the HNF3-like element at bp
22006 to 21994 using nuclear extracts from bTC3, HIT T-15,
H4IIE (a rat hepatoma cell line), BHK, and NIH 3T3 cells, and
pancreatic islets. A single common protein-DNA complex was
detected in b and liver cells, as well as human islet extracts, but
not in NIH 3T3 or BHK extracts (Fig. 7A). The binding activity
of the ubiquitously distributed USF transcription factor (16) in
each of these extracts served as an internal control in these

experiments, and similar levels were detected in bTC3, HIT
T-15, BHK, and NIH 3T3 cells (Fig. 7A).
The specificity of protein-DNA binding to the bp 22017 to
21991 probe was first determined by competition assays with
the wild-type bp 22017 to 21991 element and the PstBstpTk
M4, M5, and M6 mutants in HIT T-15 extracts. The M5 mutant did not compete, while both M4 and M6 competed efficiently (Fig. 7B). In addition, binding of the wild type and M4,
M5, and M6 mutant probes in bTC-3 extracts was directly
compared (Fig. 7C). The results of these experiments were
similar and indicated that only the M5 mutant eliminated binding to the bp 22017 to 21991 element. Together with the
transfection results, we conclude that the activator of HNF3like element at bp 22006 to 21994 was a nuclear protein
present in both liver and islet b cells.
To examine the potential involvement of HNF3b on bp
22006 to 21994 element-driven activity, we tested whether an
antibody specific for mouse HNF3b affected the formation of
the bp 22017 to 21991 complex in gel shift assays with H4IIE,
bTC3, and human islet extracts. When anti-HNF3b antibody
was preincubated with extract and then added to the bp 22017
to 21991 probe, the protein complex was quantitatively supershifted in b extracts (Fig. 8). This is a specific reaction, since
the supershifted complex was not formed by adding preimmune serum. These results point to HNF3b as the b-cell nuclear protein that binds and activates bp 22006 to 21994
element-driven expression in vivo.
HNF3b is expressed in pancreatic cells. The expression
pattern of HNF3b in relation to pdx-1 within adult mouse
pancreatic tissue was determined immunohistochemically.
While HNF3b is known to be expressed in the developing
dorsal pancreatic bud at 10 days p.c. (1) and its mRNA has also
been detected in adult pancreatic tissue and exocrine cell lines
(9), the distribution of HNF3b protein in the adult pancreas
has not been reported. We therefore compared the expression
of HNF3b and pdx-1-driven b-gal in pancreatic tissue from
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FIG. 5. Transgenic analysis of b-cell-specific regulatory regions. (A) Digestive organs of 2-day-old neonatal pups carrying a PB-hsplacZ transgene show b-gal
expression (blue) in islets within the pancreas (bracket) and not within the exocrine cells, stomach, or duodenum. The inset shows islets at higher magnification
(arrowheads). Expression is detected in islets close to the ductal epithelium and those located more distally. (B) PstBst–b-gal expression colocalizes with insulin. The
indicated islet is magnified in the inset, showing b-gal expression in blue overlapping insulin in brown. Bar, 45 mm. Abbreviations: p, pancreas; s, stomach.

mice heterozygous for a pdx-1–lacZ fusion allele, pdx-1lacZKO
(35). The pancreas of these animals is equivalent to that of
1/1 animals (35). As shown in Fig. 9A, HNF3b is expressed in
islet cells, where pdx-1–b-gal-positive cells are also found (Fig.
9E). HNF3b nuclear staining was also detected in acinar cells
within some pancreatic lobes (Fig. 9C), whereas other lobes
did not show expression (Fig. 9D). HNF3b was not detected in
the spleen or pancreatic mesenchyme (data not shown). The
variable acinar cell expression of HNF3b was similar to the
transcription pattern of the pdx-1-driven lacZ from the endogenous locus (Fig. 9F and data not shown), as well as b-gal
expression from the pdx-1 transgene XSlacZPS (Fig. 1D).
Thus, HNF3b is expressed in pancreatic cells that also express
pdx-1, particularly in the endocrine compartment, consistent
with the proposal that HNF3b is a bona fide regulator of pdx-1
transcription in vivo.
DISCUSSION
We have analyzed the basis for pancreatic islet b-cell-specific transcription of the mouse pdx-1 gene, which encodes a
homeodomain protein known to play an essential role during
pancreatic development and for which strong circumstantial
evidence that it is involved in islet b and d gene expression
exists. Our results indicate that selective expression is directed
by pdx-1 59 flanking sequences and that a significant level of
control is exerted by the sequences between nucleotides 22560
and 21880. A detailed mutational analysis of this region demonstrated that an HNF3-like element was important for activity. Thus, our data strongly suggest that at least some aspects of
pdx-1 transcription rely on HNF3b, a factor known from other

studies to be important in endodermal development (62).
However, since HNF3b is not restricted to islet b cells, selective transcription of pdx-1 likely results from HNF3b cooperating with another factor(s) having a more b-cell-restricted
expression pattern.
Initially, we found that a transgenic b-gal reporter construct
containing sequences from kb 24.5 to 18.2 of the mouse pdx-1
gene recapitulated the endoderm-specific expression pattern of
the endogenous pdx-1 gene throughout development, from
which we inferred that the cis-acting elements required for
selective transcription were contained within these sequences.
DNase I and MNase analyses on the endogenous pdx-1 gene
identified three HS sites, which spanned nucleotides 22560 to
21880 (site 1), 21330 to 2800 (site 2), and 2260 to 1180 (site
3), which were found in pdx-1-expressing bTC-3 cells but not
NIH 3T3 cells. These results indicated that the elements regulating pdx-1 expression were located within these 59 flanking
HS site sequences.
Among these three HS regions, we found that only the bp
22560 to 21880 site could direct b-cell-specific transcription
from transiently transfected pdx-1–pTk CAT chimeras. Most
importantly, these sequences also directed b-cell-specific transgene expression in vivo. While our transfection assays almost
certainly cannot detect all of the factors regulating pdx-1 transcription in vivo, these results indicated that site 2 or 3 sequences are less important in b-cell-specific expression. This
proposal is supported by the occurrence of HS site 3 at bp
2260 to 1180 over the mouse pdx-1 promoter and the observation that transcriptional activation from this region is apparently regulated by generally distributed factors (48). However,
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FIG. 6. An HNF3-like element is important in the activity of nuclease-HS site 1 in b cells. (A) The position of the nuclease-HS site 1 site within the PstBst region
is shown diagrammatically. The sequence of the bp 22031 to 21996 region is indicated. Of the 12 nucleotides between bp 22007 and 21996, 11 match an HNF3
consensus binding site (VAWTRTTKRYTY, where V 5 A, C, or G; W 5 A or T; K 5 G or T; Y 5 pyrimidine, C, or T; R 5 purine, G, or A [Fig. 3C of reference
38]); the nonconsensus nucleotide in 22007 AAGCAAACATCC 21996 is underlined. The HNF3-binding site consensus sequence (VAWTRTTKRYTY, where V 5
A, C, or G; W 5 A or T; K 5 G or T; Y 5 pyrimidine, C, or T; R 5 purine, G, or A [Fig. 3C of reference 37]) was used in the alignment. The mutated nucleotides
in PstBstpTk M1 through PstBstpTk M6 and PstBstpTk PDX-1m are indicated. The AT-rich sequences between bp 22031 and 22015 bind effectively and specifically
to PDX-1 in vitro, and the mutation in PstBstpTk PDX-1m eliminates this binding activity (data not shown). The bp 22031 to 21996 region was deleted in PstBstpTk
D22031/21996. (B and C) Wild-type and mutant PstBstpTk activity in transfected HIT T-15 (B) and bTC-3 and H4IIE (C) cells. The ratio of the pdx-1–pTk to pTk
activity is the mean 6 standard deviation of results from at least three independent transfections.

it is also possible that HS site 2 and other regions are required
for pdx-1 expression during development or in differentiated
duodenal cells. A precedent for this comes from the finding
that discrete regions of the mammalian HNF3b (45) and Drosophila snail (22) genes direct different spatial and cell-typespecific transcription patterns during embryogenesis. We are
continuing our studies with transgenic mice to determine
whether separate modules of the pdx-1 gene direct different
aspects of development- or differentiation-specific expression
and how these correlate with the locations of HS sites 1, 2,
and 3.
Maximal selective activity in transfection assays was obtained from a pdx-1–pTk chimera, PstBstpTk, spanning the bp

22560 to 21880 nuclease-HS site. The activity of this construct
was compromised by removing pdx-1 sequences from either the
59 or 39 end of this region, although a construct containing
sequences from bp 22158 to 21880 still had approximately
one-third of the activity of PstBstpTk (XmnBstpTk in Fig. 4).
Gel shift assays demonstrated that HNF3b was present in
human islet and b-cell nuclear extracts that bound to the mutationally sensitive bp 22006 to 21994 element. Since HNF3
proteins bind DNA as a monomer via their winged helix DNAbinding domain (8), it is possible that HNF3b was the only
protein present in the bp 22006 to 21996 element-binding
complex detected in liver and b-cell extracts.
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FIG. 7. Distribution and binding properties of the bp 22006 to 21994 element factor. (A) Binding to the bp 22006 to 21994 probe in extracts (15 mg)
prepared from bTC3, HIT T-15, H4IIE, BHK, and NIH 3T3 cells and human
islets. H4IIE is a rat hepatoma cell line. The major band discussed in the text is
denoted by the arrow. Lane 1 contains the probe alone. (B) Formation of the
major binding complex in HIT T-15 cell extracts (15 mg) is specifically competed
by bp 22006 to 21994 element mutants that mediate positive PstBstpTk activity.
Control binding with probe alone (lane 1), with extract (lane 2), and in the
presence of either 50-fold (lanes 3, 5, 7, and 9) or 200-fold (lanes 4, 6, 8, and 10)
excess of unlabeled wild-type or mutant bp 22017 to 21991 competitor is shown.
(C) The bp 22006 to 21994 element binding with wild-type (WT) and M4, M5,
and M6 probes in bTC-3 extracts (15 mg).

HNF3b was also shown to be present in the nuclei of the
majority of pancreatic islet cells and was detected uniformly
within acinar cells of some pancreatic lobes, while it was not
detected in other lobes. PDX-1, like HNF3b, was expressed in
islets and was distributed in a similar pattern to HNF3b in
acinar cells. Previous immunohistochemical analysis of pdx-1
expression suggested a restriction to islets in the adult pancreas
(18), since any low-intensity nonuniform staining over the
acini, although nuclear, had been rejected as nonspecific background. However, we now propose that detection of pdx-1
expression in pancreatic exocrine tissue, through the pdx-1–
lacZ fusion allele, provides a more sensitive means of detecting
bona fide low-level pdx-1 expression. We note that Finegood et
al. (13) observed incorporation of bromodeoxyuridine into a
subset of pancreatic lobes in the adult rat, suggesting that en
block formation of whole pancreatic lobes, containing both
exocrine and endocrine cells, occurs normally during pancreatic growth and remodeling. Expression of pdx-1 and HNF3b
may therefore be correlated with the state of growth of a
particular lobe. Similarly, the observed transient increase in
the level of PDX-1 in the majority of exocrine cell nuclei
following streptozotocin-induced b-cell injury (12) also suggests a link between PDX-1 and pancreatic growth during
regeneration. It remains to be seen whether PDX-1 and/or
HNF3b expression in acini is required for normal exocrine
pancreas growth and differentiation and/or fulfills a maintenance function throughout the lifetime of the pancreas. In this

respect, a potential transcriptional target for pdx-1 in the exocrine pancreas is the elastase I gene (reference 27 and references within).
The evidence that HNF3b is a positive regulator of the pdx-1
gene in vivo is threefold: (i) mutation of an HNF3-like site
within nuclease-HS site 1 region reduced b-cell-type-specific
activation; (ii) HNF3b in B-cell nuclear extracts can bind specifically to this site; and (iii) HNF3b is detected in PDX-1producing cells in vivo. Unfortunately, the role of HNF3b in
the expression of pdx-1 in vivo cannot be resolved from the
phenotype of HNF3b homozygous null mutant mice, since
these mice die in early embryogenesis prior to the outgrowth
and differentiation of the pancreatic endoderm (3, 54). During
the review of this paper, another report was published that
describes the importance of HNF3b in rat pdx-1 gene tran-

FIG. 8. HNF3b antibody recognizes the bp 22006 to 21994 element-binding
complex. Binding reactions were carried out with H4IIE (lanes 1 to 3), bTC-3
(lanes 4 to 6), or human islet (lane 7 to 10) extracts. Extracts (4 mg) were
incubated for 10 min at room temperature with HNF3b antibody before the
addition of probe. The HNF3b and antibody-supershifted (SS) complex are
labeled. Lanes: 1, 4, and 7, extract plus probe; 2, 5, 8, plus 3 ml of preimmune (PI)
serum; 3, 6, and 9, plus 3 ml of HNF3b antibody.
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FIG. 9. HNF3b staining in adult pancreas. Immunohistochemistry was used to detect HNF3b protein on sections of pancreatic tissue from pdx-1lacZKO (35) adult
heterozygotes. (A) Nuclear HNF3b is detected in endodermally derived cells within the pancreas, including islet b cells (arrowheads). (B) Insulin expression in b cells
is localized to the cytoplasm (compare with panel A). (C) Subpopulations of acinar cells also express HNF3b (arrowheads), as do the majority of ductal epithelial cells
(not shown). The intensity of HNF3b staining in the pancreas is similar to that in endodermal cells of the liver (not shown). (D) Population of acinar cells that do not
express HNF3b. (E) b-gal expression from the endogenous pdx-1 locus in pdx-1lacZKO adult heterozygotes is present in the majority of islet b cells, resembling the
pattern of HNF3b expression in islets (compare with panel A). (F) pdx-1–b-gal expression was also detected at lower levels in subpopulations of acinar cells (arrowheads
in panels E and F). The inset shows representative positive nuclei at higher magnification. Bracket in panel B indicates an islet. Bar in panel A, 30 mm (for panels A
to D); bar in panel E, 30 mm (for panels E and F).

scription (49). Interestingly, the location of the HNF3b binding site in the rat gene and the sequences surrounding this site
are very different from the mouse pdx-1 gene characterized
here. Further characterization of the mouse, rat, and human
pdx-1 genes should provide insight into the key factors that
cooperate with HNF3b to direct selective expression.
The rather general distribution of HNF3b during embryogenesis (4, 32, 45), the inactivity of PstBstpTk in liver H4IIE
cells, and the observation that a mutation of the HNF3b control element within PstBstpTk altered the level, but not the cell
specificity, of expression suggest that HNF3b is one of several
effectors that generate the correct, cell-type-specific expression
pattern of the pdx-1 gene in vivo. The bp 22560 to 21880
region contains a consensus basic helix-loop-helix (bHLH)
binding sequence, CANNTG, implicating b2/NeuroD (28, 33)

and PTF1 (26) factors in control of b-cell and acinar cellspecific transcription, respectively. b2/NeuroD appears to be
important in the expression of the rat pdx-1 gene (49). Since
pdx-1 expression in b cells is eliminated in Pax4 homozygous
mutant mice (50), this factor may also be an important regulator. Higher-resolution mapping within the bp 22560 to
21880 region will be required to identify the other key factors
involved in selective stimulation of the mouse pdx-1 gene.
Mutations in the HNF1a (61) and HNF4a (60) genes, which
encode transcription factors that were originally isolated because of their ability to activate liver-specific genes, have been
shown to contribute to maturity-onset diabetes of the young.
The biological effects of mutant forms of HNF1a and HNF4a
are unknown, although it is presumed that they reduce either
insulin production or secretion (7). Our results suggest that
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mutations in HNF3b or accessory proteins in the transcription
complex with HNF3b that cause a decrease in PDX-1 transcription factor synthesis would reduce insulin production and
also lead to disease.
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